GigaGen
  • Our Company
    • Team
    • News
  • Our Science
    • Surge and Magnify Technologies
    • Publications, Scientific Posters & Presentations
  • Pipeline
    • Oncology
    • Recombinant Polyclonals
  • Careers
  • Contact
  • Menu Menu

Targeted Oncology: Novel CTLA-4 Agents Build on Immunotherapy Foundation, Aim to Improve Efficacy/Safety

News, Uncategorized

GIGA-564 featured in the Next Wave of CTLA-4 Blockade. Read the full article.

03/30/2022
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share on Telegram
  • Share by Mail
©Copyright 2022 GigaGen. All Rights Reserved. | Privacy Policy | Terms | Disclaimer
  • Twitter
  • LinkedIn
Scroll to top